SK8402000A3 - Novel compounds - Google Patents
Novel compounds Download PDFInfo
- Publication number
- SK8402000A3 SK8402000A3 SK840-2000A SK8402000A SK8402000A3 SK 8402000 A3 SK8402000 A3 SK 8402000A3 SK 8402000 A SK8402000 A SK 8402000A SK 8402000 A3 SK8402000 A3 SK 8402000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- pyridazin
- methylpropyl
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704542A SE9704542D0 (sv) | 1997-12-05 | 1997-12-05 | Novel pyridazinone compounds |
| SE9801989A SE9801989D0 (sv) | 1998-06-04 | 1998-06-04 | Novel compounds |
| PCT/SE1998/002191 WO1999029695A1 (en) | 1997-12-05 | 1998-12-01 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK8402000A3 true SK8402000A3 (en) | 2001-03-12 |
Family
ID=26663151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK840-2000A SK8402000A3 (en) | 1997-12-05 | 1998-12-01 | Novel compounds |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6342601B1 (de) |
| EP (1) | EP1036076B1 (de) |
| JP (1) | JP2001525413A (de) |
| KR (1) | KR20010032769A (de) |
| CN (1) | CN1284079A (de) |
| AT (1) | ATE223413T1 (de) |
| AU (1) | AU1791699A (de) |
| BR (1) | BR9813373A (de) |
| CA (1) | CA2312419A1 (de) |
| DE (1) | DE69807741T2 (de) |
| EE (1) | EE200000318A (de) |
| HU (1) | HUP0100280A3 (de) |
| ID (1) | ID25628A (de) |
| IL (1) | IL136499A0 (de) |
| MX (1) | MXPA00005506A (de) |
| NO (1) | NO20002788L (de) |
| NZ (1) | NZ504452A (de) |
| PL (1) | PL340836A1 (de) |
| SK (1) | SK8402000A3 (de) |
| TR (1) | TR200001603T2 (de) |
| WO (1) | WO1999029695A1 (de) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801399D0 (sv) | 1998-04-21 | 1998-04-21 | Astra Pharma Prod | Method and apparatus for filling containers |
| US6462072B1 (en) | 1998-09-21 | 2002-10-08 | Gpi Nil Holdings, Inc. | Cyclic ester or amide derivatives |
| SI1953162T1 (sl) * | 2001-02-24 | 2012-09-28 | Boehringer Ingelheim Pharma | Ksantinski derivati, njihova priprava in njihova uporaba kot zdravila |
| GB0117583D0 (en) | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
| GB0118479D0 (en) | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7569574B2 (en) | 2002-08-22 | 2009-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| US7495005B2 (en) | 2002-08-22 | 2009-02-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, their preparation and their use in pharmaceutical compositions |
| US7482337B2 (en) | 2002-11-08 | 2009-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| DE10254304A1 (de) | 2002-11-21 | 2004-06-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| US7393854B2 (en) | 2003-01-17 | 2008-07-01 | Astrazeneca Ab | Thienopyrimidinedinones and their use in modulation of autoimmune disease |
| SE0300120D0 (sv) * | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| WO2004072029A2 (en) * | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
| DE10327439A1 (de) * | 2003-06-18 | 2005-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| US7566707B2 (en) | 2003-06-18 | 2009-07-28 | Boehringer Ingelheim International Gmbh | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| WO2005054852A1 (en) * | 2003-11-21 | 2005-06-16 | Astrazeneca Ab | Screening method |
| DE10355304A1 (de) | 2003-11-27 | 2005-06-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| WO2005053695A1 (ja) * | 2003-12-04 | 2005-06-16 | Eisai Co., Ltd. | 多発性硬化症予防剤または治療剤 |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004009039A1 (de) | 2004-02-23 | 2005-09-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel |
| US7393847B2 (en) | 2004-03-13 | 2008-07-01 | Boehringer Ingleheim International Gmbh | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions |
| US7179809B2 (en) * | 2004-04-10 | 2007-02-20 | Boehringer Ingelheim International Gmbh | 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| US7439370B2 (en) | 2004-05-10 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
| DE102004030502A1 (de) | 2004-06-24 | 2006-01-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel |
| EP1768662A2 (de) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Immunstimulatoren kleiner moleküle und assays für deren nachweis |
| DE102004043944A1 (de) | 2004-09-11 | 2006-03-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102004044221A1 (de) | 2004-09-14 | 2006-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
| BRPI0711558A2 (pt) * | 2006-05-04 | 2011-11-08 | Boeringer Ingelheim Internat Gmbh | polimorfos |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| WO2008017670A1 (en) * | 2006-08-08 | 2008-02-14 | Boehringer Ingelheim International Gmbh | Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| NZ600126A (en) * | 2007-08-17 | 2013-12-20 | Boehringer Ingelheim Int | Purine derivatives for use in the treatment of fap-related diseases |
| PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR101657960B1 (ko) * | 2008-08-15 | 2016-09-20 | 베링거 인겔하임 인터내셔날 게엠베하 | Fab-관련 질환의 치료에 사용하기 위한 푸린 유도체 |
| AU2009290911A1 (en) | 2008-09-10 | 2010-03-18 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| EP2382216A1 (de) | 2008-12-23 | 2011-11-02 | Boehringer Ingelheim International GmbH | Salzformen einer organischen verbindung |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| EA034869B1 (ru) | 2009-11-27 | 2020-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин |
| MX341025B (es) | 2010-05-05 | 2016-08-04 | Boehringer Ingelheim Int Gmbh * | Terapia de combinacion. |
| PH12012502524A1 (en) | 2010-06-24 | 2014-02-10 | Boehringer Ingelheim Int | Diabetes therapy |
| US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| EP3517539B1 (de) | 2011-07-15 | 2022-12-14 | Boehringer Ingelheim International GmbH | Substituiertes dimeres chinazolinderivat, dessen herstellung und dessen verwendung in pharmazeutischen zusammensetzungen zur behandlung von diabetes typ i und ii |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び/又はネフローゼ症候群の治療に用いるdpp−4阻害薬としてのキサンチン誘導体 |
| US20130303554A1 (en) | 2012-05-14 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Use of a dpp-4 inhibitor in sirs and/or sepsis |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| US9200005B2 (en) | 2013-03-13 | 2015-12-01 | AbbVie Deutschland GmbH & Co. KG | Inhibitor compounds of phosphodiesterase type 10A |
| US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
| AU2017251537B2 (en) | 2016-04-15 | 2020-10-08 | Abbvie Inc. | Bromodomain inhibitors |
| CN109310697A (zh) | 2016-06-10 | 2019-02-05 | 勃林格殷格翰国际有限公司 | 利格列汀和二甲双胍的组合 |
| GB202106872D0 (en) | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
| WO2023099648A1 (en) * | 2021-12-02 | 2023-06-08 | Astrazeneca Ab | Pyraolo- and triazolo-azinone compounds and their uses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1453897A (fr) * | 1965-06-16 | 1966-07-22 | Dérivés du thiophène et de thiéno pyridazines | |
| FR2478640A1 (fr) * | 1980-03-24 | 1981-09-25 | Sanofi Sa | Nouvelles thieno (2,3-d) pyridazinones-4 et thieno (2,3-d) pyridazinones-7, leur procede de preparation et leur therapeutique |
| JP3120857B2 (ja) * | 1990-02-19 | 2000-12-25 | 中外製薬株式会社 | 新規な縮合複素環化合物とこれを用いた抗喘息剤 |
| TW245719B (de) * | 1990-09-10 | 1995-04-21 | Sterling Winthrop Inc | |
| TW279162B (de) * | 1991-09-26 | 1996-06-21 | Mitsubishi Chem Corp | |
| US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
-
1998
- 1998-12-01 IL IL13649998A patent/IL136499A0/xx unknown
- 1998-12-01 ID IDW20001021D patent/ID25628A/id unknown
- 1998-12-01 SK SK840-2000A patent/SK8402000A3/sk unknown
- 1998-12-01 JP JP2000524288A patent/JP2001525413A/ja not_active Withdrawn
- 1998-12-01 MX MXPA00005506A patent/MXPA00005506A/es not_active Application Discontinuation
- 1998-12-01 CN CN98813493A patent/CN1284079A/zh active Pending
- 1998-12-01 TR TR2000/01603T patent/TR200001603T2/xx unknown
- 1998-12-01 AT AT98962754T patent/ATE223413T1/de not_active IP Right Cessation
- 1998-12-01 NZ NZ504452A patent/NZ504452A/en unknown
- 1998-12-01 KR KR1020007006064A patent/KR20010032769A/ko not_active Withdrawn
- 1998-12-01 BR BR9813373-0A patent/BR9813373A/pt not_active Application Discontinuation
- 1998-12-01 DE DE69807741T patent/DE69807741T2/de not_active Expired - Fee Related
- 1998-12-01 AU AU17916/99A patent/AU1791699A/en not_active Abandoned
- 1998-12-01 HU HU0100280A patent/HUP0100280A3/hu unknown
- 1998-12-01 CA CA002312419A patent/CA2312419A1/en not_active Abandoned
- 1998-12-01 PL PL98340836A patent/PL340836A1/xx not_active Application Discontinuation
- 1998-12-01 EP EP98962754A patent/EP1036076B1/de not_active Expired - Lifetime
- 1998-12-01 EE EEP200000318A patent/EE200000318A/xx unknown
- 1998-12-01 WO PCT/SE1998/002191 patent/WO1999029695A1/en not_active Ceased
-
1999
- 1999-01-12 US US09/214,755 patent/US6342601B1/en not_active Expired - Fee Related
-
2000
- 2000-05-31 NO NO20002788A patent/NO20002788L/no not_active Application Discontinuation
-
2001
- 2001-12-10 US US10/006,244 patent/US6770646B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6342601B1 (en) | 2002-01-29 |
| NO20002788L (no) | 2000-08-01 |
| TR200001603T2 (tr) | 2000-10-23 |
| EP1036076A1 (de) | 2000-09-20 |
| WO1999029695A1 (en) | 1999-06-17 |
| KR20010032769A (ko) | 2001-04-25 |
| EE200000318A (et) | 2001-08-15 |
| MXPA00005506A (es) | 2008-09-11 |
| JP2001525413A (ja) | 2001-12-11 |
| CA2312419A1 (en) | 1999-06-17 |
| HUP0100280A2 (hu) | 2001-10-28 |
| US20020099055A1 (en) | 2002-07-25 |
| IL136499A0 (en) | 2001-06-14 |
| NO20002788D0 (no) | 2000-05-31 |
| NZ504452A (en) | 2002-05-31 |
| EP1036076B1 (de) | 2002-09-04 |
| ATE223413T1 (de) | 2002-09-15 |
| DE69807741T2 (de) | 2004-07-15 |
| PL340836A1 (en) | 2001-02-26 |
| BR9813373A (pt) | 2000-10-03 |
| US6770646B2 (en) | 2004-08-03 |
| ID25628A (id) | 2000-10-19 |
| DE69807741D1 (de) | 2002-10-10 |
| AU1791699A (en) | 1999-06-28 |
| CN1284079A (zh) | 2001-02-14 |
| HUP0100280A3 (en) | 2003-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6770646B2 (en) | Substituted fused pyridazinone compounds; composition and use thereof | |
| CN100334093C (zh) | 噻吩并嘧啶二酮及其在调节自身免疫疾病中的用途 | |
| US7645764B2 (en) | Kinase inhibitors and methods for using the same | |
| US7435731B2 (en) | Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same | |
| KR101071438B1 (ko) | 카나비노이드 수용체 길항제로서의피라졸로[1,5-a]피리미딘 화합물 | |
| US20070049598A1 (en) | p38 Map kinase inhibitors and methods for using the same | |
| CN100358900C (zh) | 新化合物 | |
| JP2004537557A (ja) | 化学化合物 | |
| EP1641804A1 (de) | Thienopyridonderivative als kinaseinhibitoren | |
| US20080207684A1 (en) | Kinase inhibitors and methods for using the same | |
| US20080221131A1 (en) | Thienopyrimidinediones and their use in modulation of autoimmune disease | |
| US7608603B2 (en) | Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase inhibitors | |
| US7563800B2 (en) | Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors | |
| CN100354282C (zh) | 噻吩并哒嗪酮及其在调节自身免疫疾病中的用途 | |
| CZ20002039A3 (cs) | Nové pyridazinonové sloučeniny, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje |